All companies
Abbott Laboratories logo
HealthcareABT

Abbott Laboratories (ABT) Financial Forecast Calculator

Interactive 5-year forecast and DCF for Abbott Laboratories. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from Abbott Laboratories’s most recent SEC filings.

Revenue FY30
$53.39B
from $40.11B
FCF FY30
$8.32B
Margin 15.6%
Enterprise value
$118.77B
3.0× LTM revenue
Equity value
$112.26B
Net debt $6.51B
Revenue & free cash flow - history and 5-year forecast
Line (area)
Bars
Historicals from SEC EDGAR (grey). Forecast years (color) update live as you move the sliders.

Assumptions

Revenue growth (annual)
5.9%
-10.0%baseline 5.9%40.0%
Gross margin
56.7%
5.0%baseline 56.7%90.0%
Capex % of revenue
5.1%
0.0%baseline 5.1%30.0%
WACC (discount rate)
9.00%
4.0%baseline 9.0%18.0%
Terminal growth
2.50%
0.0%baseline 2.5%5.0%

Need this as an Excel model?

Keep iterating on the Abbott Laboratories forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.

income_statement.xlsx
Income statement, brown brand palette
income_statement.xlsx
Income statement, green brand palette
income_statement.xlsx
Income statement, red brand palette

Frequently asked

What does Abbott Laboratories do?+

Abbott Laboratories is a diversified global healthcare company that discovers, develops, manufactures, and sells a broad line of healthcare products. It operates across four primary segments: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals.

How does Abbott Laboratories generate revenue?+

Abbott Laboratories generates revenue primarily through its Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals segments, with Medical Devices contributing approximately 48% of its revenue. Over 60% of its revenue comes from outside the United States, making it exposed to global healthcare trends.

What is Abbott Laboratories' typical capital expenditure as a percentage of revenue?+

Abbott Laboratories typically allocates 4.0% to 5.0% of its revenue towards capital expenditures. This spending is heavily weighted towards growth capex, funding new manufacturing lines for products like FreeStyle Libre and cardiovascular devices.

How does the Exact Sciences acquisition impact Abbott Laboratories' financial model?+

The Exact Sciences acquisition, expected to close in Q2 2026, is a key focus of Abbott's financial model, specifically assessing its financial impact and integration. This acquisition adds over USD 3 billion in annual revenue and will significantly increase Goodwill and Intangible Assets on the balance sheet.

What is the primary purpose of a financial model for Abbott Laboratories?+

The primary purpose of a financial model for Abbott Laboratories is to project its future cash flows and earnings to determine its equity valuation. A specific focus is placed on assessing the financial impact and integration of the pending Exact Sciences acquisition.

Can I download an Excel financial model for Abbott Laboratories?+

Yes, an Excel financial model for Abbott Laboratories is available for download. This model projects the company's financials from FY2026 to FY2030.

Have more financial modelling questions? Contact us

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview